Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis
Authors: Fireman, Bruce; Goddard, Kristin S; Klein, Nicola P; Timbol, Julius; Zerbo, Ousseny | Lancet (London, England) | October 19, 2024 | PubMed abstract
